Huntsman Cancer Institue

Salt Lake City, Utah 84113

0 studies enrolling now · 4 studies all time

What they study most

Central Nervous System Tumor, Head and Neck, Leukemia, Lymphoma, Multiple Myeloma, Neoplasms, Solid Tumor, Solid Tumors Refractory To Standard Therapy, Squamous Cell Cancer

Studies at this site

• A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma — Running, not enrolling
• Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment — Running, not enrolling
• Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer — Completed
• Kanglaite Injection Phase I Study — Completed